PhaseRx, Inc.
PZRX
PZRX was delisted on the 2nd of February, 2018.
9 hedge funds and large institutions have $2.98M invested in PhaseRx, Inc. in 2016 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
13% more funds holding
Funds holding: 8 → 9 (+1)
45% less capital invested
Capital invested by funds: $5.41M → $2.98M (-$2.44M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RFC
Regions Financial Corp
Birmingham,
Alabama
|
+$71.3K |
| 2 |
Goldman Sachs
New York
|
+$46.3K |
| 3 |
Millennium Management
New York
|
+$15.1K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$11.1K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$587 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$515K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$753 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Fidelity Investments
Boston,
Massachusetts
| $2.16M | -$515K | -158,031 | -16% |
|
|
PA
2
Perceptive Advisors
New York
| $514K | – | – | – |
|
|
RFC
3
Regions Financial Corp
Birmingham,
Alabama
| $164K | +$71.3K | +21,876 | +52% |
|
|
4
Goldman Sachs
New York
| $84K | +$46.3K | +14,213 | +77% |
|
|
5
Millennium Management
New York
| $39K | +$15.1K | +4,630 | +43% |
|
|
6
Bank of America
Charlotte,
North Carolina
| $9K | +$11.1K | +3,397 | New |
|
|
TRCT
7
Tower Research Capital (TRC)
New York
| $2K | -$753 | -231 | -24% |
|
|
BIM
8
BlackRock Investment Management
Wilmington,
Delaware
| $1K | – | – | – |
|
|
9
UBS Group
Zurich,
Switzerland
| – | +$587 | +180 | New |
|
PZRX Hedge Fund Activity: Q3 2016 in Review
9 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in PhaseRx, Inc. (PZRX) for Q3 2016, worth a combined $2.98M — down 45% from $5.41M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new PZRX positions and 1 closed out — a net gain of 1 holder — while 3 added to existing stakes and 2 trimmed.
The largest buyer was Regions Financial Corp, adding an estimated $71.3K. The largest seller was Fidelity Investments, cutting an estimated $515K.
- 9 institutional investors held PhaseRx, Inc. (PZRX) as of Q3 2016, up from 8 in Q2 2016.
- Funds reported $2.98M of PhaseRx, Inc. stock for Q3 2016, down 45% quarter-over-quarter.
- 2 funds opened new PhaseRx, Inc. positions in Q3 2016 and 1 closed out, a net change of +1 holder.
- The largest PhaseRx, Inc. buyer in Q3 2016 was Regions Financial Corp, an estimated $71.3K added.
- The largest PhaseRx, Inc. seller in Q3 2016 was Fidelity Investments, an estimated $515K sold.
Based on aggregated 13F filings for Q3 2016.